Cite
HARVARD Citation
Mikah, P. et al. (2016). Dynamic changes of alkaline phosphatase are strongly associated with PSA-decline and predict best clinical benefit earlier than PSA-changes under therapy with abiraterone acetate in bone metastatic castration resistant prostate cancer. BMC cancer. 16 (1), pp. 1-9. [Online].